Abstract:Pulmonary arterial hypertension (PAH) is a chronic disease characterized by a progressive elevation in mean pulmonary arterial pressure. This occurs due to abnormal remodeling of small peripheral lung vasculature resulting in progressive occlusion of the artery lumen that eventually causes right heart failure and death. Current therapeutic options for PAH are limited and focused mainly on reversal of pulmonary vasoconstriction and proliferation of vascular cells. Although these treatments can relieve disease symptoms, PAH remains a progressive lethal disease.Bone morphogenetic proteins (BMPs) and their receptors were required for PAH-induced right ventricular hypertrophy. Emerging data suggest that restoration of BMP type II receptor (BMPR2) signaling in PAH is a promising alternative that could prevent and reverse pulmonary vascular remodeling. BMPR2 mutations have been identified in >70% of familial and roughly 15% of sporadic PAH cases. Wingless (Wnt) are a family of secreted glycoproteins with varying expression patterns and a range of functions, Wnt signaling pathway is divided into canonical signaling pathway and non-canonical signaling pathway. A recent study reports that interaction between BMP and Wnt closely associated with lung development, those cascade coordination regulation stem cell fate which determine lung branching morphogenes. The promoting effect of BMPR2 on proliferation, survival, and motility of endothelial cells was through recruiting Wnts signaling pathway, the interaction between BMP and Wnt closely associated with lung development.Therefore, in this review, we outline the latest advances of BMP and Wnt signaling pathway in the pathogenesis of PAH and disease progression.

[Advances in molecular mechanism of vascular remodeling in pulmonary arterial hypertension].

Epigenetic Regulation of Pulmonary Arterial Hypertension

Suppression of Tissue Inhibitors of Metalloproteinases May Reverse Severe Pulmonary Arterial Hypertension.

Regulatory role of autophagy in development of pulmonary artery hypertension

Potential Role of Cellular Senescence in Pulmonary Arterial Hypertension

Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension

Advances in research on molecular mechanisms for the proliferation of pulmonary artery smooth muscle cells and their intervention

Unraveling the role of HIF and epigenetic regulation in pulmonary arterial hypertension: implications for clinical research and its therapeutic approach

Stem/Progenitor Cells and Pulmonary Arterial Hypertension.

Panorama of artery endothelial cell dysfunction in pulmonary arterial hypertension

Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension

Mitochondrial dysfunction in pulmonary arterial hypertension

Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension

Stem/Progenitor Cells And Pulmonary Arterial Hypertension

Exploring the pathogenesis of pulmonary vascular disease

Metabolic reprogramming, oxidative stress, and pulmonary hypertension

New progress in diagnosis and treatment of pulmonary arterial hypertension

Emerging connectivity of programmed cell death pathways and pulmonary vascular remodelling during pulmonary hypertension

Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension

A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension

Cell Death in Pulmonary Arterial Hypertension